What Do Analysts Predict for MSTR?

This None we watched MicroStrategy rise 2.2% to a price of $178.8 per share. The mid-cap Software company is now trading -62.54% below its average target price of $477.33. Analysts have set target prices ranging from $110 to $950 per share for MicroStrategy, and have given the stock an average rating of buy.

MicroStrategy has an elevated short interest of 42.3%. The stock's short ratio, or the number of days needed for all shorts to cover their positions, is 6.31. Only 0.08% of the company's shares are owned by insiders, indicating that management does not have a deep alignment of interest with its shareholders. 71.1% of MicroStrategy shares are held by institutional investors, which indicates a high level of confidence in the stock.

Institutions Invested in MicroStrategy

Holder Shares Date Reported Percentage Value
Capital International Investors 1,384,999 2022-09-29 15% $247,637,825
Vanguard Group, Inc. (The) 897,907 2022-09-29 10% $160,545,774
Blackrock Inc. 700,791 2022-09-29 7% $125,301,432
Renaissance Technologies, LLC 283,200 2022-09-29 3% $50,636,160
Capital World Investors 271,700 2022-09-29 3% $48,579,960
Morgan Stanley 237,127 2022-09-29 3% $42,398,308
State Street Corporation 209,961 2022-09-29 2% $37,541,027
Geode Capital Management, LLC 172,235 2022-09-29 2% $30,795,618
Two Sigma Advisers, LP 130,100 2022-09-29 1% $23,261,880
Toroso Investments, LLC 107,768 2022-09-29 1% $19,268,918

For these reasons, we consider that the MicroStrategy is the subject of mixed market sentiment.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.